Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Raaj Medisafe India's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 42.77.
Raaj Medisafe India's Days Inventory for the
three
months ended in Mar. 2026 was 81.14.
Raaj Medisafe India's Days Payable for the
three
months ended in Mar. 2026 was 27.53.
Therefore, Raaj Medisafe India's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 96.38.
Raaj Medisafe India (BOM:524502) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Raaj Medisafe India Cash Conversion Cycle Related Terms
Raaj Medisafe India Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Raaj Medisafe India's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524502 vs SW, PKG, IP: Cash Conversion Cycle Comparison
For the Packaging & Containers subindustry, Raaj Medisafe India's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raaj Medisafe India Cash Conversion Cycle vs Packaging & Containers Industry
For the Packaging & Containers industry and Consumer Cyclical sector, Raaj Medisafe India's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Raaj Medisafe India's Cash Conversion Cycle falls into.
Raaj Medisafe India Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Raaj Medisafe India's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raaj Medisafe India (BOM:524502) has a Cash Conversion Cycle of 96.38 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Raaj Medisafe India and its competitors.
Is Raaj Medisafe India's Cash Conversion Cycle too high?
Raaj Medisafe India's current Cash Conversion Cycle is 96.38. The Packaging & Containers industry median Cash Conversion Cycle is 87.43. Raaj Medisafe India's value of 96.38 is 10.2% above this industry median. Overall, Raaj Medisafe India has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Raaj Medisafe India's Cash Conversion Cycle compare to SW and PKG?
Raaj Medisafe India's Cash Conversion Cycle of 96.38 can be compared against companies in the Packaging & Containers industry. The industry median Cash Conversion Cycle is 87.43. Raaj Medisafe India's value of 96.38 is 10.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Packaging & Containers company?
The median Cash Conversion Cycle among Packaging & Containers companies is 87.43, based on 394 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raaj Medisafe India's current Cash Conversion Cycle of 96.38 is 10.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Raaj Medisafe India and its competitors. For the Packaging & Containers industry, the median Cash Conversion Cycle is 87.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raaj Medisafe India's current Cash Conversion Cycle is 96.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raaj Medisafe India stock overvalued right now?
Based on GuruFocus' analysis, Raaj Medisafe India (BOM:524502) is currently considered Fairly Valued. The stock's GF Value™ is ₹78.23, compared to a current price of ₹75.01 — trading 4.1% below its estimated fair value. The current Cash Conversion Cycle is 96.38 and 10.2% above the Packaging & Containers industry median of 87.43. Raaj Medisafe India's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Raaj Medisafe India (BOM:524502), the current Cash Conversion Cycle is 96.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raaj Medisafe India (BOM:524502) Overvalued in 2026?
Based on GuruFocus' analysis, Raaj Medisafe India stock appears to be undervalued.
The current stock price of ₹75.01 is trading 4.1% below its estimated GF Value™ of ₹78.23.
GuruFocus considers Raaj Medisafe India to be Fairly Valued.
Key valuation signals for BOM:524502:
Cash Conversion Cycle: 96.38
GF Value™: ₹78.23 vs. price of ₹75.01 (4.1% below fair value)
Industry Position: 10.2% above the Packaging & Containers median
No single metric tells the full story. See the BOM:524502 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raaj Medisafe India Ltd is an India-based company engaged in manufacturing and selling plastic bottles, caps, plugs, aluminum caps, plastic liners, and related products. The firm operates in two segments: Plastic and HHygiene. The Company earns revenue mainly from the sale of packaging items.
64GF Score
Get the complete analysis for BOM:524502
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524502 has been successfully added to your 
